GLP-1

News

Man with measuring tape around his torso

GLP-1 drugs linked to pancreatitis, gallbladder problems

Users of weight-loss therapies based on GLP-1 agonists have been warned to be aware of a rare complication, pancreatitis, that can be severe.

News

Roche claims midstage win for obesity injectable

Roche reports weight loss of up to 22.5% with its injectable GIP/GLP-1 agonist obesity drug, setting up phase 3, but will it be too late to the table?

News

Wegovy pill shows strong early uptake, as rival looms

Encouraging early sales data for oral Wegovy has buoyed Novo Nordisk, as Lilly waits for an FDA decision on its rival orforglipron, now due in Q2.

News

JPM: Novo Nordisk CEO gives insight into new strategy

Novo Nordisk CEO Mike Doustdar covers oral Wegovy, DTC sales channels, and an under-appreciated obesity pipeline in a wide-ranging presentation.

News

FDA seeks changes to GLP-1, flu shot labels

The FDA has asked manufacturers of GLP-1 drugs used for weight loss to remove warnings of suicidal thinking, but added warnings to flu shots.

News

Study finds weight returns more quickly in GLP-1 users

People who use drugs like GLP-1 agonists to lose weight regain it more quickly than those who use a conventional approach of diet and exercise.

GLP-1 drugs linked to pancreatitis, gallbladder problems

Roche claims midstage win for obesity injectable

Wegovy pill shows strong early uptake, as rival looms

JPM: Novo Nordisk CEO gives insight into new strategy

FDA seeks changes to GLP-1, flu shot labels

Study finds weight returns more quickly in GLP-1 users

Allogeneic cell therapy isn’t dead, with Brian Culley

How to meet your physicians where they are online

GLP-1

Editor's Picks